<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font32 { font-size : 32; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font23 { font-size : 23; } .font24 { font-size : 24; } .font28 { font-size : 28; }</style>
 <body>
  <p>
   <span class="font32">COVID- </span>
   <span class="font28">patients </span>
   <span class="font24">risk </span>
   <span class="font23">et√Ç </span>
   <span class="font20">{border-style </span>
   <span class="font20">viral </span>
   <span class="font19">immune </span>
   <span class="font19">infections </span>
   <span class="font19">px;} </span>
   <span class="font18">#ffffff;} </span>
   <span class="font18">multiple </span>
   <span class="font17">treatment </span>
   <span class="font16">Continue </span>
   <span class="font16">dosing </span>
   <span class="font15">DMTs </span>
   <span class="font15">associated </span>
   <span class="font15">infection </span>
   <span class="font15">lymphocyte </span>
   <span class="font15">natalizumab </span>
   <span class="font15">phase </span>
   <span class="font15">potential </span>
   <span class="font14">complications </span>
   <span class="font14">coronavirus </span>
   <span class="font14">immunosuppressive </span>
   <span class="font14">respiratory </span>
   <span class="font14">severe </span>
   <span class="font14">DMT </span>
   <span class="font14">Engl. </span>
   <span class="font14">Yes, </span>
   <span class="font14">disease </span>
   <span class="font14">high </span>
   <span class="font14">pandemic </span>
   <span class="font14">px; </span>
   <span class="font14">relatively </span>
   <span class="font14">{font-family </span>
   <span class="font13">Maintenance </span>
   <span class="font13">cladribine </span>
   <span class="font13">depletion </span>
   <span class="font13">font-size </span>
   <span class="font13">low </span>
   <span class="font13">prolonged </span>
   <span class="font13">sclerosis </span>
   <span class="font13">shedding. </span>
   <span class="font13">virus </span>
   <span class="font13">Med. </span>
   <span class="font13">Suspend </span>
   <span class="font13">Theoretical </span>
   <span class="font13">double; </span>
   <span class="font13">fingolimod </span>
   <span class="font13">modulators </span>
   <span class="font13">months </span>
   <span class="font13">result </span>
   <span class="font13">treated </span>
   <span class="font12">Elsevier </span>
   <span class="font12">Moderate </span>
   <span class="font12">Scler. </span>
   <span class="font12">antiviral </span>
   <span class="font12">based </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">case </span>
   <span class="font12">cause </span>
   <span class="font12">considered </span>
   <span class="font12">continue </span>
   <span class="font12">depending </span>
   <span class="font12">dose </span>
   <span class="font12">higher </span>
   <span class="font12">human </span>
   <span class="font12">infection. </span>
   <span class="font12">ocrelizumab </span>
   <span class="font12">patient </span>
   <span class="font12">recommended </span>
   <span class="font12">reconstitution </span>
   <span class="font12">relapsing </span>
   <span class="font12">response </span>
   <span class="font12">solid; </span>
   <span class="font12">therapies </span>
   <span class="font12">transplant </span>
   <span class="font12">use </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font12">/mm </span>
   <span class="font12">COVID-. </span>
   <span class="font12">Disord. </span>
   <span class="font12">IRT </span>
   <span class="font12">Probably </span>
   <span class="font12">SARS-CoV- </span>
   <span class="font12">Yes </span>
   <span class="font12">active </span>
   <span class="font12">acute </span>
   <span class="font12">bold </span>
   <span class="font12">cell </span>
   <span class="font12">centre </span>
   <span class="font12">clear </span>
   <span class="font12">continous </span>
   <span class="font12">count </span>
   <span class="font12">counts </span>
   <span class="font12">courier; </span>
   <span class="font12">delay </span>
   <span class="font12">em; </span>
   <span class="font12">health </span>
   <span class="font12">immunosuppression </span>
   <span class="font12">increased </span>
   <span class="font12">increases </span>
   <span class="font12">infected </span>
   <span class="font12">infectious </span>
   <span class="font12">intermittent </span>
   <span class="font12">likely </span>
   <span class="font12">management </span>
   <span class="font12">moderate </span>
   <span class="font12">need </span>
   <span class="font12">neurologists </span>
   <span class="font12">neurotropic </span>
   <span class="font12">novel </span>
   <span class="font12">present </span>
   <span class="font12">problem </span>
   <span class="font12">progressive </span>
   <span class="font12">pt;} </span>
   <span class="font12">public </span>
   <span class="font12">recommendations </span>
   <span class="font12">reduce </span>
   <span class="font12">resource </span>
   <span class="font12">safe </span>
   <span class="font12">sclerosisN. </span>
   <span class="font12">start </span>
   <span class="font12">time </span>
   <span class="font12">tract </span>
  </p>
 </body>
</html>
